eLaws
|
eCases
|
United States Code
|
Federal Courts
|
Sign In
Sign Up
eLaws
eCases »
United States Code
Federal Courts »
Home
»
Rulemaking
» Draft and Revised Draft Guidances for Industry; Availability: Describing Product-Specific Bioequivalence Recommendations
Draft and Revised Draft Guidances for Industry; Availability: Describing Product-Specific Bioequivalence Recommendations
Document ID:
FDA-2007-D-0369-0087
Document Type:
Notice
Agency:
Food And Drug Administration
Topics:
No Topics associated with this document
Federal Register Number:
2012-14477
View Document:
Details Information
Abstract:
Waiting for the guidance from K. Geoffrey Wu
Document Subtype:
Notice of Availability
Received Date:
June 14 2012, at 12:00 AM Eastern Daylight Time
Start-End Page:
35688 - 35689
Page Count:
2
Comment Start Date:
June 14 2012, at 12:00 AM Eastern Standard Time
Comment Due Date:
August 13 2012, at 11:59 PM Eastern Standard Time
Comments
Total:
2
OFW Law - Comment
Posted:
08/07/2012
ID:
FDA-2007-D-0369-0090
Comment Period Closed
Aug 13,2012 11:59 PM ET
Pfizer Inc. - Comments
Posted:
01/07/2013
ID:
FDA-2007-D-0369-0101
Comment Period Closed
Aug 13,2012 11:59 PM ET
Related Documents
Total:
0
No documents available.
Draft and Revised Draft Guidances for Industry; Availability: Describing Product-Specific Bioequivalence Recommendations
Details Information
Comments
Posted: 08/07/2012 ID: FDA-2007-D-0369-0090
Aug 13,2012 11:59 PM ET
Posted: 01/07/2013 ID: FDA-2007-D-0369-0101
Aug 13,2012 11:59 PM ET
Related Documents